AHCO
AdaptHealth Corp.
NASDAQ · Healthcare · Medical - Devices · US
$7.28
+16.00%Year over year
Reported trailing growth
- Revenue
- +19.8%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- -61.6%
- Operating cash flow
- +1.7%
Forward estimates
Based on analyst estimates
- Revenue
- -5.7%
- EBITDA
- +4103.8%
- EPS
- +99.3%
Three-year CAGR
- Revenue
- +3.0%
- EBITDA
- -5.4%
- EBIT
- -0.7%
- Net income
- —
- EPS
- —
- Free cash flow
- +23.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026